Research Progress on BRCA1/2 Mutations in Sporadic Gastric Cancer: Risk Stratification, Surgical Prognosis, and Individualized Treatment
Annali Italiani di Chirurgia · 09.02.2026 · 97 (2)
DOI: 10.62713/aic.4379 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Annali Italiani di Chirurgia, online erschienen am 09.02.2026. Verfasst von Meiqiong Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The 305 Hospital of PLA, 100017 Beijing, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Genes, BRCA1, Genes, BRCA2. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Gastric cancer is one of the most prevalent malignant tumors worldwide. Sporadic gastric cancer accounts for more than 80% of all gastric cancer cases, and its pronounced heterogeneity underlies the substantial variability in clinical outcomes and the complexity of treatment strategies. The breast cancer gene 1 (BRCA1) and breast cancer gene 2 (BRCA2) are core regulators of the DNA damage homologous recombination repair (HRR) pathway, and their pathogenic mutations are closely associated with hereditary breast and ovarian cancer syndrome. Recent evidence has shown that BRCA1/2 mutations also exist in some sporadic gastric cancer patients and may profoundly affect tumor biological behavior, clinical prognosis, and treatment response. This article systematically reviews the latest research progress on BRCA1/2 mutations in sporadic gastric cancer, focusing on their incidence and molecular characteristics, their impact on patients' postoperative prognosis, and their potential value as novel biomarkers for guiding individualized therapy, thereby providing a theoretical basis for clinical risk stratification and tailored treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, The 305 Hospital of PLA, 100017 Beijing, China.
- Department of General Surgery, The 305 Hospital of PLA, 100017 Beijing, China.
- Department of Clinical Laboratory, The 305 Hospital of PLA, 100017 Beijing, China.
- Department of Gastroenterology, The 305 Hospital of PLA, 100017 Beijing, China.
Zitieren
APA
Chen, M., Dong, Y., Wang, R., & Cui, H. (2026). Research Progress on BRCA1/2 Mutations in Sporadic Gastric Cancer: Risk Stratification, Surgical Prognosis, and Individualized Treatment. Annali Italiani di Chirurgia, 97(2). https://doi.org/10.62713/aic.4379
Vancouver
Chen M, Dong Y, Wang R, Cui H. Research Progress on BRCA1/2 Mutations in Sporadic Gastric Cancer: Risk Stratification, Surgical Prognosis, and Individualized Treatment. Annali Italiani di Chirurgia. 2026;97(2). doi:10.62713/aic.4379
BibTeX
@article{Chen2026,
author = {Chen, Meiqiong and Dong, Yi and Wang, Ru and Cui, Haihong},
title = {Research Progress on BRCA1/2 Mutations in Sporadic Gastric Cancer: Risk Stratification, Surgical Prognosis, and Individualized Treatment},
journal = {Annali Italiani di Chirurgia},
year = {2026},
volume = {97},
number = {2},
doi = {10.62713/aic.4379}
}
EUVIMED